To address this question, we took advantage of the scRNA-seq dataset from Yost et al. profiling T cells within paired BCC and SCC tumor samples pre- and post-anti-PD-1 therapy (72). This evidence concerns the gene PDCD1 and skin basal cell carcinoma.